Decrease in licensing agreements as pharmaceutical companies reign in spending

被引：0

|

作者：

不详

机构：

来源：

PHARMACEUTICAL PATENT ANALYST | 2012年 / 1卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：21 / 21

页数：1

相关论文

共 50 条

[1] Do Managed Entry Agreements Contribute to Lower Pharmaceutical Spending?
Vokinger, Kerstin N.
[J]. JAMA HEALTH FORUM, 2023, 4 (12):
[2] Quality agreements between pharmaceutical/biopharmaceutical companies and their contractors
Blasini, RP
[J]. BIOPHARM INTERNATIONAL, 2005, 18 (04) : 66 - +
[3] LICENSING AGREEMENTS
POWER, A
[J]. MISSISSIPPI LAW JOURNAL, 1971, 42 (02): : 169 - 177
[4] Differentiation of innovation strategies based on pharmaceutical licensing agreements: Insight from Korean pharmaceutical firms
Song, Chie Hoon
Leker, Jens
[J]. TECHNOLOGY ANALYSIS & STRATEGIC MANAGEMENT, 2019, 31 (02) : 169 - 185
[5] RESTRICTIVE CLAUSES IN LICENSING AGREEMENTS - THE PHARMACEUTICAL-INDUSTRY IN DEVELOPING-COUNTRIES
CIESLIK, J
[J]. JOURNAL OF WORLD TRADE, 1984, 18 (05) : 415 - 428
[6] IN-LICENSING AS A BUSINESS STRATEGY FOR PHARMACEUTICAL COMPANIES: A FRAMEWORK FOR THE NIGERIAN INDUSTRY
Keshi, C. B.
[J]. VALUE IN HEALTH, 2016, 19 (07) : A823 - A823
[7] ASPECTS OF LICENSING AGREEMENTS
不详
[J]. BRITISH CHEMICAL ENGINEERING, 1968, 13 (08): : 417 - &
[8] The Eleventh Circuit holds that agreements in which pharmaceutical companies pay generic companies not to compete may be valid
Garrigues, A
[J]. JOURNAL OF LAW MEDICINE & ETHICS, 2004, 32 (01): : 181 - 184
[9] Changes in the type and amount of spending disclosed by Australian pharmaceutical companies: an observational study
Parker, Lisa
Karanges, Emily A.
Bero, Lisa
[J]. BMJ OPEN, 2019, 9 (02):
[10] Compensation in International Licensing Agreements
Preet S. Aulakh
S. Tamer Cavusgil
MB. Sarkar
[J]. Journal of International Business Studies, 1998, 29 : 409 - 419

← 1 2 3 4 5 →